1. Home
  2. CTM vs ELOX Comparison

CTM vs ELOX Comparison

Compare CTM & ELOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CTM

Castellum Inc.

HOLD

Current Price

$0.54

Market Cap

63.1M

Sector

Technology

ML Signal

HOLD

Logo Eloxx Pharmaceuticals Inc. Common Stock

ELOX

Eloxx Pharmaceuticals Inc. Common Stock

N/A

Current Price

$13.20

Market Cap

60.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CTM
ELOX
Founded
2019
1999
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
63.1M
60.3M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
CTM
ELOX
Price
$0.54
$13.20
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $38.25
AVG Volume (30 Days)
★ 326.9K
17.7K
Earning Date
11-06-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 83.33
41.67
EPS
★ N/A
N/A
Revenue
★ $52,866,001.00
N/A
Revenue This Year
$6.00
N/A
Revenue Next Year
$7.11
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 18.10
N/A
52 Week Low
$0.48
$10.00
52 Week High
$1.36
$23.40

Technical Indicators

Market Signals
Indicator
CTM
ELOX
Relative Strength Index (RSI) 32.73 40.05
Support Level $0.48 $10.74
Resistance Level $0.66 $14.65
Average True Range (ATR) 0.02 1.28
MACD -0.01 -0.04
Stochastic Oscillator 27.14 21.89

Price Performance

Historical Comparison
CTM
ELOX

About CTM Castellum Inc.

Castellum Inc is focused on building a successful technology services, solutions, and products company in the areas of cybersecurity, IT, electronic warfare, information warfare, system modernization, and information operations with businesses in the defense, federal, civilian, and commercial markets. Services include intelligence analysis, software development, software engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering. The company maintains one operating and reportable segment, which is the delivery of products and services in the areas of information technology, electronic warfare, information warfare and cybersecurity in the governmental and commercial markets.

About ELOX Eloxx Pharmaceuticals Inc. Common Stock

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.

Share on Social Networks: